HLA-G and viral infectious disease: We used an in vivo NK cytotoxicity assay, in which splenocytes from wild-type and β2microglobulin-deficient (MHC-Ineg) mice are co-injected into recipients whose NK cells were activated by virus infection or synthetic Toll-like receptor ligands.